Abstract. Previous studies have suggested that estradiol can reduce the ischemia/reperfusion (I/R) injury in skin flaps. However, the mechanism, particularly the signal pathways involved in this protective effect are not well established. In the current study, an I/R injury model was established in rats to explore the connection between estradiol protection during I/R injury and extracellular signal-regulated kinase (ERK) signaling. Healthy male Wistar rats were divided into five groups (n=10): Control group (group I), I/R group (group II), saline group (group III), estradiol group (group IV) and inhibitor (PD-98059) group (group V). The survival rate of the flap was compared between groups, morphological changes were observed by hematoxylin and eosin staining of sections, and terminal deoxynucleotidyl transferase dUTP nick end labeling was performed to identify apoptotic cells and determine the apoptotic index. To further investigate the mechanism, western blot analysis was performed to assess the protein level of ERK 1/2 , phospho-ERK 1/2 , and mitogen-activated protein kinase phosphatase 1 (MKP-1). The results of the present study demonstrated that estradiol therapy can reduce I/R injury and decrease the apoptosis index in an axial skin flap model. The inhibitor of the ERK pathway (PD-98059) partially abolished the effects of estradiol, which involve the phosphatase enzyme MKP-1. Taken together, the findings of the present study indicate that estradiol may act by reducing the expression of MKP-1, mediating the expression/activation changes of the ERK pathway and subsequently reduce the level of apoptosis and the I/R injury the axial flap. Estrogen may be used to mitigate the adverse reaction caused by ischemia-reperfusion injury and effectively improve the survival rate and survival quality of free skin flap and improve patient prognosis.
Introduction
Skin flap transplantation is one of the most commonly used, and effective methods to repair tissue defects and reconstruct organs. However, the treatment is impeded due to the occurrence of ischemia/reperfusion (I/R) injury in the process of transplantation, which produces toxic compounds, including lipid peroxide and reactive oxides. Thus, patients may require longer hospitalization, multiple unexpected surgeries and increased costs (1) . A number of studies have reported that I/R injury of skin flaps caused a series of complex pathophysiological processes mediated by various cell types and factors. The main mechanisms may involve the production of reactive oxygen species (ROS), the adhesion and aggregation of neutrophils, calcium overload, apoptosis and other processes (2) (3) (4) (5) (6) . Apoptosis is considered to be an important factor in I/R injury of skin flaps (7) . The mechanism of I/R damage may involve the excessive production of oxygen free radicals and the cross-links between proteins, resulting in dysfunction of proteins with enzyme activity and altered gene transcription (8, 9) . Extracellular signal-regulated kinase (ERK) is an important downstream mediator in the mitogen-activated kinase (MAPK) pathway, with a crucial role in cellular signal transduction pathways involved in cell proliferation, differentiation, morphology, cytoskeleton construction, apoptosis, and carcinogenesis (10, 11) . Previous research had demonstrated that the ERK signaling pathway is closely associated with I/R injury (12) . Darling et al (13) reported that the protective effect of myocardial ischemia in the heart tissue of rabbits was mediated by the ERK pathway, rather than the phosphoinositide 3-kinase pathway. Jung et al (14) reported that troglitazone induces apoptosis of various types of cells, which may be linked to inhibition of the ERK pathway. Therefore, I/R injury in skin flaps may be mediated by the ERK pathway. Mitogen-activated protein kinase phosphatase 1 (MKP-1), which is also termed dual specificity phosphatase 1, is a specific negative regulator of the ERK pathway, and can block substrate activity by promoting the serine/threonine or tyrosine dephosphorylation (15) . The current treatment measures for I/R injury of skin flaps include pretreatment of the skin flap, drug treatment (growth factor, L-selection, calcium antagonists), biological technology (antibodies, gene therapy) and sound wave therapy (16). Drug treatments have the best prospects for clinical application. The hormone estrogen has received attention for its potential use in the therapy of I/R injury. Currently, research findings have demonstrated that minute quantities of estrogen can alleviate the I/R injury of skin flaps; the effect may be mediated by NO production in vascular endothelial cells, anti-oxygenation and anti-apoptosis (17) . The underlying mechanism of estradiol postconditioning protection remains incompletely understood. In order to determine whether the application of estradiol would be useful for the clinical treatment of I/R injury, the current study was designed investigate the association between estradiol, apoptosis and the ERK signaling pathway. Animal model establishment. Wistar rats were anesthetized by intraperitoneal injection of 2% pentobarbital sodium (20 ml/kg). The rats were put into a supine position with the neck extended and the area was shaved in preparation for the procedure. The operation area was sterilized with iodophor and covered with sterile surgical towel. As previously described by Manson et al (18) , an axial pattern skin flap of 3x6 cm in size was made of each rat, with the superficial artery and vein in the abdominal wall acting as the pedicle. The blood flow of the flap was blocked completely by a microvascular clip to clamp the vessel pedicle for 6 h and the flap was sutured to their original position with 5-0 stitches. During the period of the ischemia, anesthesia with was maintained (2% pentobarbital sodium). After 6 h of ischemia, the clamp was removed and the I/R injury model has been established.
Estradiol postconditioning relieves ischemia/reperfusion injury in axial skin flaps of rats, inhibits apoptosis and alters the MKP-1/ERK pathway

Materials and methods
Ethics
Experimental groups. Rats were fed to >250 g and divided randomly into five groups (n=10 per group) as follows: Group I (control group), after the flap was harvested, it was sutured to its own donor site without clamps to reduce blood flow; Group II (I/R group), the I/R injury model was established with no treatment; Group III (saline group), the I/R injury model was established and normal saline (2 ml/kg) injected; Group IV (estradiol group), the I/R injury model was established treated with estradiol (100 µg/kg) injected; Group V (inhibitor group), I/R model rats were co-treated with estradiol (100 µg/kg) and PD-98059 which may inhibit Mek-1, the upstream protein of Erk (0.3 mg/kg). Rats of groups III-V were treated with saline, estradiol, PD-98059 and estradiol by intraperitoneal injection in the right lower abdomen after the surgery, and at day 2, 4 and 6 postoperatively.
Observation of the skin flap. The gross condition of the skin flap was observed at days 2, 4 and 6 postoperatively. The color, hair growth, survival area and the inflammation exudation of the flaps were monitored by daily observation.
Determination of flap survival. Images of the flaps were captured using a digital camera at 7 days postoperatively, and computerized planimetry was performed using Image-Pro Plus v6.0 (Media Cybernetics, Inc., Rockville, MD, USA). The necrotic area was recorder, which was obviously different in color compared with the normal tissue. The survival rate of the flap was obtained by dividing the survival area of the skin flap by the total area of the flap.
Histology analysis. The rats were anesthetized at 7 days postoperatively. A full-thickness skin sample of 0.5x0.5 cm in size near the vascular pedicle was obtained and fixed in 10% formalin overnight. The sections were dehydrated in alcohol, rehydrated in xylene, and embedded in wax. 10 µm consecutive section, label for each slice, and standby, a normal slice was manufactured. The sections were stained with hematoxylin and eosin. The histological characteristics of the tissues were evaluated under a light microscope, 10 fields of view were captured per slice.
Apoptosis index. Apoptosis was determined by TUNEL assay in each rat. The skin flap tissues were sectioned into 10 µm by using a microtome. Sections were dewaxed in xylene for 10 min and dehydrated in an ascending ethanol gradient. After preparation of washing, the slices were soaked in the TUNEL reaction solution at room temperature for 1 h. Subsequently, the slices were washed in PBS for 3 times for 5 min, fixed in 4% paraformaldehyde for 15 min and sealed by methanol containing 3% H 2 O 2 for 10 min at room temperature. Finally, after being immersed in the diaminobenzidine for 5 min, the sections were stained with hematoxylin and observed under a light microscope. For each TUNEL-stained section, three randomly selected high power fields were imaged. Apoptotic nuclei were deeply brown stained. Three random high-power fields were imaged from each section. Apoptotic and non-apoptotic cells were identified by Image Pro Plus version 6.0 software (Media Cybernetics, Inc., Rockville, MD, USA). The apoptotic index was equal to apoptotic cells divided by the total cells.
Western blot analysis. At 7 days after the surgery, an area of the skin flap near the vascular pedicle was harvested. The skin layer and adipose tissue were removed, and the tissue was cut into pieces and stored in a cryogenic refrigerator (-80˚C). RIPA lysis buffer and protease inhibitors were added to the tissues (100:1), and the samples were incubated on ice, centrifuged at 12,000 x g for 10 min at 4˚C and the supernatant extracted 30 min after centrifugation. Subsequently, the protein lysates (50 mg/lane) were loaded into 12% SDS-PAGE gels (Beyotime Institute of Biotechnology), separated by electrophoresis and transferred to a nitrocellulose membrane. The membrane was blocked in 5% non-fat powdered milk at room temperature with gentle shaking for 2 h and then washed in TBS-Tween 20 three times for 10 min each. Subsequently, the membrane was incubated with diluted primary antibody Erk (1:1,000; cat. no. 4348S; Cell Signaling Technology, Inc.), p-Erk (1:1,000; cat. no. 4370S; Cell Signaling Technology, Inc.), MKP-1 (1:1,000; cat. no. ab1351; Abcam), GAPDH (1:1,000; cat. no. AG019; Beyotime Institute of Biotechnology) in 5% BSA at 4˚C overnight with gentle shaking. The membrane was washed by TBS-Tween for three times for 10 min each, then incubated with secondary antibody (Erk, p-Erk with goat anti-rabbit; 1:1,000; cat. no. A0239; Beyotime Institute of Biotechnology; MKP-1 with donkey anti-goat; 1:1,000; cat. no. A0266; Beyotime Institute of Biotechnology; GAPDH with goat anti-rat; 1:1,000; cat. no. A0192; Beyotime Institute of Biotechnology) for 1.5 h at room temperature. Finally, the proteins were detected by the method of ECL color (BeyoECL Plus, cat. no. P0018; Beyotime Institute of Biotechnology) and all the target protein bands were analyzed using Image J software (National Institutes of Health, Bethesda, MD, USA).
Statistical analysis. All the statistics were analyzed with SPSS software 17.0 (SPSS, Inc., Chicago, IL, USA). Experimental results are presented as the mean ± standard deviation. One-way analysis of variance was used to determine the statistical difference among the groups, and Levene test was used for the evaluation of homogeneity of variances. The Tukey-Kramer test was used for pairwise comparison and the Bonferroni test was used for multiple comparisons. Pearson coefficient was used to analysis the flap survival rate and apoptosis index correlation. P<0.05 was considered to indicate a statistically significant difference.
Results
Observation of the skin flap. Following the surgery to establish I/R, different degrees of swelling were observed in the I/R skin flap model rats and the skin appeared a violet color. Necrosis gradually emerged in the skin flaps. Necrotic areas appeared that were black, hard and had no hair growth in the I/R group and saline group. Compared to the original skin, the thickness of skin flap of I/R group and saline group increased significantly. However, the degree of swelling gradually declined in the control group, estradiol group and inhibitor group. Only a small are of necrosis appeared in the suture edge and the skin flap had no obvious differences to the normal skin in these three groups.
Flap survival rate determination. On postoperative day 7, the skin flaps were images (Fig. 1A) . Quantification of the skin flap survival rate is presented in Fig. 1B . The survival rates of the flap were 98.13±2.67% in the control group, 67.36±22.94% in the I/R group, 68.19±21.11% in saline group, 94.05±9.27% in the estradiol group and 78.87±15.65% in the inhibitor group. Compared with the control group, the survival rate of the flap was significantly decreased in the I/R group (P<0.05). There was no significant change in the survival rate in the I/R skin flap model rats that received saline (saline group) and those that were untreated (I/R group; P>0.05). The survival rate of the estradiol group was significantly higher than the I/R group (P<0.05). Additionally, the survival rate was significantly higher in the estradiol group than in the inhibitor group (P<0.05).
Histological analysis. At 7 day the I/R model was established, the tissue structure of the control group was normal, with cells arranged orderly and almost no observable infiltration of inflammatory cells. The following features were observed in the I/R and saline groups: Stratum corneum exfoliation, tissue edema, massive neutrophil aggregation, adhesion, loss of normal tissue structure and skin tissue necrosis. In the estradiol and inhibitor groups, the flap tissue inflammation and edema were mild, and the tissue structure was normal (Fig. 2) .
Apoptosis index. TUNEL staining was used to detect apoptosis and the TUNEL-positive cells were stained brown. The apoptotic index was 5.69±1.475% in the control group, 45.02±8.128% in the I/R group, 49.18±5.801% in the saline group, 11.89±2.721% in the estradiol group and 18.95±4.04% in the inhibitor group. Compared with the control group, the apoptosis index was significantly increased in flap sections from the I/R group (P<0.05). Compared with the index in the I/R group, apoptosis was obviously decreased by estradiol treatment, and furthermore, the ERK inhibitor PD-98059 partially eliminated the effect of estradiol (Fig. 3) .
Western blot analysis. The levels of ERK pathway proteins, ERK, p-ERK and MKP-1, were detected by western blotting. Compared with the I/R group, the levels of ERK were increased in the estradiol group, while the level of MKP-1 was decreased. PD98059 (inhibitor group) inhibited the increased activation of ERK (phosphorylation), but did not affect the protein expression of ERK and MKP-1. Unexpectedly, the levels of ERK and MKP-1 in the I/R group and saline group were marginally increased compared with the control group, which may be cause by the stress reaction to I/R injury (Fig. 4) .
Correlation analysis. The Pearson coefficient of correlation analysis (r=-0.595, P=0.01) showed a significant negative correlation between apoptosis index and survival rate of skin flap (Fig. 5) .
Discussion
The current study demonstrated that estradiol therapy reduced the I/R injury of an axial flap. Additionally, inhibition of ERK signaling partially abolished the effect of estradiol, which suggested that the protective effect of estradiol may be mediated through the ERK pathway. The findings also demonstrated that apoptosis has an important role in I/R injury and inhibition of apoptosis may be an important strategy for the treatment of I/R injury.
I/R injury is the dysfunction and structural damage to tissues or organs caused flowing the loss and recovery of blood flow (19) . A previous report indicated that the necrosis Figure 2 . Hematoxylin and eosin-stained sections of skin flap tissue at 7 days after I/R surgery. Magnification, x400. Scale bar, 50 µm. The tissue was filled with a large number of neutrophils in group II and III, with only a small amount in group I, IV and V. Control group (group I), I/R group (group II), saline group (group III), estradiol group (group IV), inhibitor group (group V). I/R, ischemia/reperfusion. rate in pedicle flaps following I/R injury was 5-10% (20) . Lipid peroxides, reactive oxygen species, toxic substances and severe inflammatory reaction in patients produced by I/R injury may prolong the duration of patient hospitalization, increase the number of operations require and increase treatment costs, which directly influences the treatment effects of surgery and increases the medical burden of patients (1). However, not all of the ischemic tissue or organs may be damaged after the recovery of blood flow. Various factors affect the occurrence and development of I/R injury, including ischemia duration, collateral circulation, oxygen demand and reperfusion conditions (21) . The process of skin flap I/R injury involves a variety of mechanisms to cooperate with each other, which forms a series of linked cascade reaction, resulting in the increased I/R injury and the tissue damage of the skin flap. If the chain reaction is not terminated in a timely manner, the survival rate of the flap is greatly threatened. Therefore, how to use multifactor interventions or drug preconditioning methods to terminate or inhibit certain pathways involved in I/R injury is currently a focus of basic and clinical research in this area. Estrogen, a female hormone, not only dominates the development and maintenance of female reproductive organs and secondary sex characteristic, but also promotes the retention of water and sodium, the deposition of calcium in bones, and influences the endocrine system, cardiovascular system, metabolism and bone growth. Previous research has demonstrated that estrogen reduces I/R injury in the brain, heart and liver (22) (23) (24) . Furthermore, estrogen may to improve the level of NO and increase the survival area of random skin flaps (25) . In the current study, inflammation was reduced, apoptosis was inhibited and the survival area of the axial flap was increased in the rats that were treated with estradiol. The results suggested that estradiol had the similar effect in the axial flap as in previous studies. Thus, similar experiments should be performed applying estrogen to free flaps.
Apoptosis is an independent, orderly and natural death process. The occurrence of apoptosis in tissues following I/R is associated with the severity of ischemia and reperfusion time. Numerous reports have demonstrated that apoptosis is mediated by multiple mechanisms during I/R injury (26) (27) (28) . ROS generated in the I/R-injured area may damage the DNA and mitochondria, and induce the lipid peroxidation of the cell membrane, which affects signal transduction. Additionally, protein cross-linking causes reduce enzyme activities and altered gene transcription, thus resulting in cell apoptosis. Furthermore, inactivation of Bcl-2 protein is induced by calcium overload and a variety of Ca 2+ -dependent endonucleases that induce the degradation of DNA, activate tumor necrosis factor signal transduction pathway, mediate the p53 pathway and promote the apoptosis (29) . An association between apoptosis and the survival rate of the axial flap was observed in the current study. Almost no hair growth was observed on the flap surface in groups that had high levels of apoptosis after I/R injury, which was detected by TUNEL. Skin ulceration and necrosis were observed at the flap edge following I/R injury. However, less apoptosis was detected in the flaps of rats that had receive estradiol injection, and the hair growth on its surface was close to normal, suggesting that estradiol reduces the apoptosis induced by I/R injury in skin flaps.
With the development of molecular biology, more research on estradiol has provided a deeper understanding of the signaling pathway. It was previously reported that estrogen stimulation causes rapid and transient activation of the MAPK protein kinase, that occurred within a few min (30) . Another study reported that the estradiol receptor is closely associated with the activity of p38 MAPK, and estradiol can regulate the inflammatory response by regulating the activity of the p38 pathway (31) . In brain astrocytes, osteoblasts and glioma cells, ERK signaling is rapidly activated by estradiol (32, 33) . By complaining between the control group and the other I/R groups, the present demonstrated that the ERK pathway was activated in this experiment. The level of ERK also was increased by estradiol, which had a direct impact on the survival rate of skin flap. In addition, when the ERK pathway was inhibited by PD98059, the survival rate of skin flap was partially reduced and the apoptosis rate was increased. It demonstrated that ERK pathway has an important role in the effect of estradiol.
It has also been reported that an imbalance in expression between MKP-1 and ERK may be one of the important mechanisms that mediate the occurrence and development of tumors (34) . Serini et al (35) reported that the mechanism of apoptosis in lung cancer cells induced by docosahexaenoic acid was associated with the increased expression of MKP-1 and downregulation of the ERK pathway. The expression of MKP-1 in the I/R group and saline group were increased in the current model, which may be caused by the stress of I/R injury. Whereas the expression of MKP-1 in the estradiol group was reduced compared with the other three groups, and the levels of ERK and p-ERK were increased, which indicates that the effect of estrogen on ERK pathway may be mediated through MKP-1.
In summary, the findings of the current study suggest that estradiol reduces I/R injury in an axial skin flap. It was also demonstrated that the ERK pathway and apoptosis have important roles in the effect of estradiol in this model. However, inhibition of the ERK pathway combined with estradiol treatment only partially reduced the effect of estradiol on the survival rate of the flap, indicating that there are other factors and pathways involved in the effect of estradiol on the survival the skin flap in this model. Further studies are required to determine the precise mechanisms, and to provide novel methods for clinical treatment of I/R injury.
